An Open-Label Study of the Efficacy of 18F-FSPG PET/CT in Subjects With Intracranial Cancers
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2016
At a glance
- Drugs BAY 949392 (Primary)
- Indications Brain cancer
- Focus Diagnostic use
- Sponsors Piramal Imaging
- 31 Aug 2016 Status changed from active, no longer recruiting to discontinued.
- 16 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016.
- 16 Jun 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2016.